Investment Q&A

Q: Could you please provide the 1 and 3-yr revenue and eps growth projections for fortinet? In your opinion, is it a buy or do you have a better suggestion for this sector?

thx,

Q: What is your opinion on Mainstreet Equity - it seems to be doing much better than a lot of other REIT investments. Is it technically a REIT? Their management seem to be running it very well.
Thanks

Q: Could you shed light on the change in BCE EPS since 2022 when it was a little above $2.50. EPS is currently below $1.50. It seems this is not due to an increased share count. What's the story?

Many thanks!

Q: This is about the Van Eck MREIT etf symbol MORT. Good buy here, with a high dividend and rates about to come down? Outlook for the dividend and share price please over the next few years as rates come down. Thx.

Q: Is the selloff of GSY a little overdone given the transition timeline and the ongoing input from the CEO? If so, is it in bargain territory?
With appreciation,
Ed

Q: Hi,
I didn't understand your answer about Brian 's question posted today. (July 4th)
To my limited understanding, your answer should point out to EMA as a better option. Lower pay out ratio. Higher dividend growth. Or am I misinterpreting your answer.

Q: In many of your recent answers as well as your report, you mention "interest rate decreases" and that they could help stocks like Telus and BCE, TD and BNS. I am wondering how much of a decrease this would have to be, as I am reading many articles that suggest we are in an aura of higher for longer, and interest rates will not be going back to the ultra low rates we have seen in prior years. So my question is, in your opinion, what percentage decrease would we have to see before there would be some sustainable upside movement to these stocks? Thanks.

Q: Could this stock be a good play on AI over the next 10 years?

Q: Could I please have your view of this company.

Q: I have owned EIF in registered and non registered accounts over the years and generally have been satisfied with its combination of relatively high yield and modest growth. Management seems quite competent in operating their two, quite different divisions of aerospace and manufacturing. However, I am beginning to question their purchase of Northern Mat and now their purchase of a small ( 40 acres ) sawmill in Quebec. They justify their sawmill purchase as a way to integrate with NM and penetrate the Quebec market. Seems and odd approach to me.

The stock has stalled recently and that’s OK but I wonder if they have taken “ their eye off the ball” and may suffer the consequences. This is more of a gut feeling than sound analysis but your thoughts on EIF would be appreciated.
Thanks. Derek.

Q: Good morning,

I am thinking of adding Gibson Energy at an initial 1-2% weight. Looking for income, moderate dividend growth, and some price appreciation potential. I am a little light in the energy space with current holdings in CNQ/SU/WCP, and am hoping you will think this might be a decent addition.

Thoughts?

Thanks as always.

Q: 5i, In my RRSP have 3 US stocks NVDA, JPM, BRK.B , soon to start withdrawing, I would like to find CAD equivalent for them, would you please suggest a replacement. Does it make sense to keep in my RRSP all in CAD stocks?

Q: CEO stepped down and stock drops around 8%
sounds like a problem somewhere

Q: Follow up on your SBC comment on HPS:
there is nothing in the SBC situation that should be of any surprise here. If options are granted then there are consequences.
My point is: management is fully aware already of SBC impact so why would they wait for quarterly results with disclosure?
Don’t they have a duty to disclose material information impact ahead of the results?

Q: There was a report on the news that Ottawa Hydro needs build a substation every year now instead of every five years. This is due to population increase but also due to EVs and heat pump installations.
This is of course not unique to one city or Canada.
Who would benefit from this increase demand in infrastructure build up?

Q: What are your current thoughts on MDA. Has the recent announcement of the $1 billion contract for the Canadarm3 changed the outlook for this company?

Q: Calamos has started these structured etf's the first of which commenced May 1. They are based on the S&P or the Nasdaq or the Russell. A new monthly fund starts each month with the aim to protect all the invested capital if the etf is held for one year with a capped upside of approximately 10%. They are targeting retirees who cannot replace lost capital as an alternative to holding cash. Structured investing isn't new however the etf wrapper providing capital gains after a one year hold for US residents and a 100% protection rather than some lessor protection as well as a .7% MER all seem to provide substantial improvement compared with other prior structured offerings regarding fees and advertised protection as well as tax treatment on gains in a cash account. Calamos also seems to have a long history of options and hedging investment and claims a significant expertise. As a retiree I am seeking, respectfully and if possible, Peter's assessment of this series of etf's as a way to seek equity-like returns based on the S&P etf set up Calamos is offering as an alternative to a money market holding or even an HSAV.CA corporate class holding which provides capital gains but at around 5% instead of the greater potential on offer. Any comment on the reset of downside protection and upside cap each year would be appreciated. Finally if there is any possible liquidity issue that needs consideration please comment. I recognize this as a big ask however these etf's should have wide interest among retirees seeking a US equity play which aims to protect against any capital loss while providing double the current return of a risk-free holding which likely applies to a substantial portion of your subscription base. Thank you in advance Peter. Hope you're not taking the summer off!!!

Q: I saw this article on Reuters re NVO and assume that's why it has come off the past couple of days. Does this issue also affect LLY? If no, is it time to switch? If yes, is it time to get out of NVO? "Patients using Novo Nordisk's wildly popular weight-loss drug Wegovy and its similar medicines for type 2 diabetes may be at increased risk for a sight-threatening eye condition, according to data from a study published on Wednesday."

Q: Is there a comparable (covered call strategy, risk, rate of return, and multi-sector approach) etf that trades on the US market?
Thank you

Q: Looking at ETF SPYG for my $US Acct. Holdings are sub-set (about 228) of S&P 500 said to have better growth. MER=0.04%.

Appears similar to VOO, VUG, MER also similar. Looking for growth, not income. For 3-5 year hold, Please comment on SPYG and compare to the two Vanguard ETFs.

Thank you,
IslandJohn